Second surgery for progressive glioblastoma: a multi-centre questionnaire and cohort-based review of clinical decision-making and patient outcomes in current practice.
Paul M BrennanR BorchertC CoulterG R CritchleyB HallD HollimanI PhangS J JefferiesS KeniL LeeI LiaquatH J MarcusS ThomsonL ThorneM VintuA N WigginsM D JenkinsonS ErridgePublished in: Journal of neuro-oncology (2021)
This is the most wide-ranging examination of contemporaneous practice in management of GBM progression. Without evidence-based guidelines, the variation is unsurprising. We propose consensus guidelines for consideration, to reduce heterogeneity in decision making, support data collection and analysis of factors influencing outcomes, and to inform clinical trials to establish whether second surgery improves patient outcomes, or simply selects to patients already performing well.
Keyphrases
- decision making
- minimally invasive
- clinical trial
- coronary artery bypass
- clinical practice
- primary care
- end stage renal disease
- healthcare
- multiple sclerosis
- newly diagnosed
- ejection fraction
- chronic kidney disease
- surgical site infection
- prognostic factors
- quality improvement
- big data
- single cell
- coronary artery disease
- cross sectional
- randomized controlled trial
- adipose tissue
- metabolic syndrome
- percutaneous coronary intervention
- machine learning
- weight loss
- phase ii
- patient reported outcomes
- data analysis